Back
Catalyst Pharmaceuticals Stock Predictions
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
69
CPRX
Catalyst Pharmaceuticals
Last Price:
$23.07
Seasonality Move:
6.55%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Catalyst Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 39.3% based on the past 18 years of stock performance.
-
Catalyst Pharmaceuticals has risen higher in 10 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Catalyst Pharmaceuticals Stock Undervalued?The current Catalyst Pharmaceuticals [CPRX] share price is $23.07. The Score for CPRX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
CPRX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Catalyst Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 39.3% based on the past 18 years of stock performance.
Catalyst Pharmaceuticals Stock Rating
Buy
69
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals overpriced?
-
Catalyst Pharmaceuticals has risen higher in 10 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Catalyst Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
catalystpharma.com
52-Week Data
52-Week High:
26.16
52-Week Low:
14.47
Prediction Charts
Market Cap:
2.8B
Price in USD:
23.07
Volume:
2.2M
Beta:
1.09
Technical Analysis
SMA50:
22.83
SMA100:
22.35
SMA200:
20.56
52-Wk Change:
52.58%
Stock Predictions
-
Is Catalyst Pharmaceuticals stock public?Yes, Catalyst Pharmaceuticals is a publicly traded company.
-
What is the Catalyst Pharmaceuticals stock quote today?The Catalyst Pharmaceuticals stock price is 23.07 USD today.
-
How to buy Catalyst Pharmaceuticals stock online?You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-18 | 21.78 | 22.08 | 22.16 | 21.53 |
| Mar-19 | 22.03 | 22.60 | 22.74 | 21.94 |
| Mar-20 | 22.28 | 23.16 | 23.17 | 22.21 |
| Mar-21 | 23.25 | 24.23 | 24.48 | 23.17 |
| Mar-24 | 24.66 | 25.74 | 26.16 | 24.50 |
| Mar-25 | 25.75 | 25.72 | 26.01 | 25.43 |
| Mar-26 | 25.94 | 25.15 | 25.96 | 25.02 |
| Mar-27 | 25.08 | 24.84 | 25.40 | 24.64 |
| Mar-28 | 24.90 | 24.69 | 24.98 | 24.25 |
| Mar-31 | 24.26 | 24.25 | 24.50 | 23.52 |
| Apr-1 | 24.33 | 23.92 | 24.49 | 23.75 |
| Apr-2 | 23.66 | 24.46 | 24.59 | 23.53 |
| Apr-3 | 23.54 | 24.11 | 24.24 | 23.26 |
| Apr-4 | 23.49 | 23.07 | 24.27 | 22.85 |
Catalyst Pharmaceuticals Earnings
Catalyst Pharmaceuticals Earnings Report: Per Share Catalyst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Catalyst Pharmaceuticals Forecast Revenue Growth
Catalyst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.37 per share.
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.